Subcutaneous Administration Of Monoclonal Antibodies Works Just As Well As Intravenous Method For COVID-19 Treatment, Researchers Report

HealthDay (12/7, Thompson) reports, “Monoclonal antibodies have been shown to dramatically reduce risk of hospitalization and death if given within five days of developing symptoms of COVID,” and now, researchers “report that giving monoclonal antibodies...